CORMEDIX INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number
CORMEDIX INC. (CRMD) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number of 2.64 million shares as of 2022-12-31, per its 10-K filed 2023-03-30.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber · last filed 2023-03-30
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 2.64M shares.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 1.93M shares.
- 2020-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 1.42M shares.
- 2019-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 932.96K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number |
|---|---|
| 2022-12-31 | 2.64M shares 10-K · filed 2023-03-30 |
| 2021-12-31 | 1.93M shares 10-K · filed 2022-03-29 |
| 2020-12-31 | 1.42M shares 10-K · filed 2021-03-30 |
| 2019-12-31 | 932.96K shares 10-K · filed 2020-03-16 |
| 2019-09-30 | 788.03K shares 10-Q · filed 2019-11-14 |
| 2019-06-30 | 767.24K shares 10-Q · filed 2019-08-14 |
| 2019-03-31 | 737.82K shares 10-Q · filed 2019-05-13 |
| 2018-12-31 | 3.48M shares 10-K · filed 2019-05-29 |
| 2018-09-30 | 2.88M shares 10-Q · filed 2018-11-14 |
| 2018-06-30 | 2.78M shares 10-Q · filed 2018-08-14 |
| 2018-03-31 | 2.64M shares 10-Q · filed 2018-05-15 |
| 2017-12-31 | 2.48M shares 10-K · filed 2018-03-19 |
| 2017-09-30 | 2.15M shares 10-Q · filed 2017-11-09 |
| 2017-06-30 | 2.58M shares 10-Q · filed 2017-08-09 |
| 2017-03-31 | 2.49M shares 10-Q · filed 2017-05-10 |
| 2016-12-31 | 2.14M shares 10-K · filed 2017-03-16 |
| 2014-12-31 | 481.83K shares 10-K · filed 2015-03-12 |
| 2014-03-31 | 706.52K shares 10-Q · filed 2014-05-15 |
| 2013-12-31 | 587.28K shares 10-K · filed 2015-03-12 |
| 2013-09-30 | 965.33K shares 10-Q/A · filed 2014-03-04 |
| 2013-06-30 | 1.39M shares 10-Q/A · filed 2014-03-04 |
| 2013-03-31 | 1.48M shares 10-Q · filed 2014-05-15 |
| 2012-12-31 | 961.03K shares 10-K · filed 2014-03-31 |
| 2012-09-30 | 875.96K shares 10-Q/A · filed 2014-03-04 |
| 2012-06-30 | 286.40K shares 10-Q/A · filed 2014-03-04 |
| 2012-05-01 | 45.00K shares 10-K · filed 2013-03-27 |
| 2012-04-30 | 45.00K shares 10-Q/A · filed 2013-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |